TO PHARMACEUTICALS LLC has a total of 20 patent applications. It decreased the IP activity by 72.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals are STAYBLE THERAPEUTICS AB, CHORD THERAPEUTICS S A R L and DAK LAB AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Bar-Lev Schleider Lihi | 9 |
#2 | Taubenfeld Sid | 6 |
#3 | Gallily Ruth | 4 |
#4 | Lihi Bar-Lev Schleider | 3 |
#5 | Bar Lev Schleider Lihi | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020115751A1 | Cannabis-based compositions for the treatment of alzheimer's disease and dementia | |
WO2020115750A1 | Cannabis-based compositions for the treatment of migraine and headache | |
WO2019224824A1 | Cannabis-based compositions for the treatment of autistic spectrum disorders | |
WO2019159185A1 | Compositions and methods for the treatment of protein energy wasting | |
WO2019130215A1 | Cannabis compositions for the treatment of inflammatory skin disorders | |
US2019314297A1 | Combination therapy of cbd and copaxone | |
WO2017168422A1 | Cannabionid and cannabis-based compositions and methods for the treatment of inflammatory conditions of the gastrointestinal tract |